Skip to main content
OABI logo

OABI · OmniAb, Inc. · Investor Relations

Track OABI — free
$4.87 -0.12 (-2.40%) At close · Oct 2
Market Cap
$670.25M
Shares
145.39M
Volume · Oct 2 1.62M Avg daily vol (3M) 1.42M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-10-06 15:00 UTC Investor and Analyst Day Presentation

Recent news

Date Headline
2026-09-14 OmniAb to Host Investor & Analyst Day on October 6, 2026
2026-08-26 OmniAb to Participate in Upcoming Investor Conferences
2026-08-17 OmniAb Raises 2026 Financial Guidance
2026-08-17 OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
2026-08-06 OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
2026-07-16 OmniAb to Report Second Quarter 2026 Financial Results on August 6
2026-07-13 OmniAb Names Amechi Nwachuku Chief Operating Officer
2026-05-07 OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
2026-04-24 OmniAb to Participate in Three Upcoming Investor Conferences
2026-04-21 OmniAb to Report First Quarter 2026 Financial Results on May 7
2026-03-04 OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
2026-02-24 OmniAb to Participate at the Leerink Partners Global Healthcare Conference
2026-02-19 OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
2025-12-15 Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
2025-12-04 OmniAb to Hold OmniUltra Virtual Investor Event on December 15
2025-11-17 OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
2025-11-04 OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Past events

Date Event Type
2026-09-15 H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-09-09 Nasdaq/LD Micro Summit Series Event
2026-08-06 Q2 2026 Financial Results and Business Update Call Earnings call
2026-06-02 Jefferies Global Healthcare Conference Conference
2026-05-28 Benchmark 6th Annual Healthcare House Call Virtual Investor Conference Conference
2026-05-07 Q1 2026 Financial Results & Business Update call Earnings call
2026-05-06 H.C. Wainwright 2nd Annual Royalty Company Virtual Conference Conference
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2026-03-04 Q4 2025 Financial Results & Business Update call Earnings call
2025-12-15 OmniUltra Launch Virtual Investor Event Event
2025-11-17 Jefferies Global Healthcare Conference – London Conference
2025-11-11 Stifel 2025 Healthcare Conference Conference
2025-11-06 2025 Truist Securities BioPharma Symposium Event
2025-11-04 Q3 2025 Financial Results & Business Update call Earnings call
2025-09-09 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-08-06 Q2 2025 Financial Results & Business Update call Earnings call
2025-06-05 Jefferies Global Healthcare Conference Conference
2025-05-29 Benchmark 2025 Healthcare House Call Virtual Conference Conference
2025-05-21 RBC Capital Markets Global Healthcare Conference Conference
2025-05-20 H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq Conference
2025-05-13 H.C. Wainwright 1st Annual Royalty Company Virtual Conference Conference
2025-05-08 Q1 2025 Financial Results & Business Update earnings call Earnings call
2025-03-18 Q4 2024 Financial Results & Business Update earnings call Earnings call
2024-11-19 Stifel 2024 Healthcare Conference Conference
2024-11-19 Jefferies London Healthcare Conference Conference

Source: https://investors.omniab.com/overview/default.aspx

Key facts CIK 1846253 CUSIP 68218J103 13F (30d) 4 filings 4 filers Visit website Investor relations